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SUMMARY
The manner by which genotype and environment
affect complex phenotypes is one of the fundamental
questions in biology. In this study, we quantified the
transcriptome—a subset of the metabolome—and,
using targeted proteomics, quantified a subset of
the liver proteome from 40 strains of the BXD mouse
genetic reference population on two diverse diets.
We discovered dozens of transcript, protein, and
metabolite QTLs, several of which linked to meta-
bolic phenotypes. Most prominently, Dhtkd1 was
identified as a primary regulator of 2-aminoadipate,
explaining variance in fasted glucose and diabetes
status in both mice and humans. These integrated
molecular profiles also allowed further characteriza-
tion of complex pathways, particularly the mitochon-
drial unfolded protein response (UPRmt). UPRmt
shows strikingly variant responses at the transcript
and protein level that are remarkably conserved
among C. elegans, mice, and humans. Overall, these
examples demonstrate the value of an integrated
multilayered omics approach to characterize com-
plex metabolic phenotypes.
INTRODUCTION
The central dogma of molecular biology states that genetic infor-
mation encoded in DNA is first transcribed by RNA polymerase,
then translated by ribosomes into proteins. However, the DNA
sequence of a gene provides little information for predicting
when, where, and to what extent its associated RNA and protein
products will be expressed. Since the advent of microarray tech-
nology, comprehensive gene expression patterns—i.e., the tran-
scriptome—can be precisely and comprehensively quantified
across large populations. Unfortunately, transcript levels gener-
ally have only modest correlation with the levels of correspond-
ing proteins (Ghazalpour et al., 2011; Gygi et al., 1999; Schwan-
ha¨usser et al., 2011), and genetic variants similarly affecting both
the transcript and peptide levels of a gene are relatively uncom-
mon (Albert et al., 2014; Skelly et al., 2013). As proteins in
most cases are more directly responsible than transcripts in
the regulation of cellular pathways—and ultimately phenotypic
traits—there is a critical need for efficient, large-scale, and accu-
rately quantitative proteomics methods to complement tran-
scriptomic data sets.
Over the past decade, the development of discovery mass
spectrometry (‘‘shotgun’’) has allowed the first large-scale
studies on quantitative proteomics. In this approach, protein ex-
tracts are cleaved into short peptide sequences, which are then
chromatographically separated and analyzed by tandem mass
spectrometry. This allows the untargeted discovery of thousands
of peptides, but if the number of unique peptide fragments in a
sample significantly exceeds the number of available sequencing
cycles (as in whole proteome extracts), any individual peptide
will be inconsistently sampled across repeat analyses. This re-
duces the technical reproducibility but moreover means that
the number of peptides consistently quantified across all (or
most) samples decreases as the study size increases (Karpie-
vitch et al., 2012). Consequently, discovery mass spectrometry
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strategy has yielded mixed results in large population studies
(Ghazalpour et al., 2011; Holdt et al., 2013), particularly as spe-
cific peptides of interest cannot be targeted, and the most
consistently identifiedpeptides are biased toward thoseof higher
abundance (Callister et al., 2006). To overcome these hurdles,
selected reaction monitoring (SRM) was developed, which per-
fects technical reproducibility and allows consistent multiplexed
quantitation of target proteins bydeploying amass spectrometric
measurement assay that is specific for each targeted peptide
(Lange et al., 2008a). Thus, hundreds of target peptides can be
consistently and accurately quantified across large populations
of samples. Recent studies in yeast have shown that the proteins
and transcripts of genes are typically controlled by different,
distinctmechanisms (Albert et al., 2014; Picotti et al., 2013). How-
ever, these hypotheses have not been well tested in mammalian
genetic reference populations (GRPs) through multilayered tran-
scriptomic and proteomic strategies.
Large GRPs are frequently used to determine to which extent
phenotypic variation is driven by genetic variants (i.e., herita-
bility), and to subsequently identify genes driving such variation.
These genes can be identified by genome-wide association
studies (GWASs) or by quantitative trait locus (QTL) mapping,
approaches that have been applied to various species and
have led to the successful identification of dozens of major allelic
variants (Andreux et al., 2012; De Luca et al., 2003; Deeb et al.,
1998; Yvert et al., 2003). In mammals, the murine BXD family is
the largest and most well-studied GRP, consisting of !150
recombinant inbred strains descended from C57BL/6J (B6)
and DBA/2J (D2) (Andreux et al., 2012). Using 40 strains of this
population on both chow (CD) and high fat (HFD) diets, we
have obtained major metabolic phenotypes and established
a multilayered data set focused on 192 metabolic genes ex-
pressed in the liver. For all genes, we know the sequence vari-
ants, transcript levels, and protein levels in all cohorts. These
data are further supplemented with targeted metabolite analysis
in the liver and serum, generating the first large-scale multilay-
ered quantitative picture of any cellular process in the BXD
population.
RESULTS
Protein Targeting across a Genetically and
Environmentally Diverse Murine Population
Wefirst selected 192metabolic proteins for study, with particular
focus on genes regulating mitochondria and general energy
metabolism. For each gene, synthetic peptides were generated
based on established assays (Picotti et al., 2010) (Figure 1A) to
accurately quantify each protein across all cohorts. To validate
peptide measurements, we compared the coefficients of varia-
tion (CV) among technical and biological peptide replicates.
Both technical and biological replicates showed a high degree
of reproducibility (CV ! 0.09 and 0.12, respectively), indicating
the quantification of targeted peptides is sufficiently accurate
across large, diverse populations. More importantly, the results
for biological replicates reveal nearly equally high overall re-
producibility (r > 0.98; Figure 1B), suggesting low biological vari-
ance within each cohort, particularly relative to cross-cohort
variance (CV!0.33); 82.1% of the quantified peptides are highly
variable (CV > 0.20), indicating that the biological error (i.e., vari-
ation within a cohort) is much smaller than the variation induced
by differences in genotypes and diet. We observed nearly com-
plete quantification of all 192 proteins across all cohorts, with
only !60 missing peptide counts out of !15,000 measurements
(i.e., 99.6% completion; Figure 1C, top). This completion is
similar to the level of completeness achieved by microarrays
(Figure 1C, bottom) and is a major contrast to shotgun-acquired
proteomics, which typically have completeness of !70% (Kar-
pievitch et al., 2012).
It has been well established that transcriptomic networks of
many metabolic processes covary quite well, e.g., within the
electron transport chain or within the citric acid cycle (Ihmels
et al., 2002). At the protein level, proteins that function in com-
mon biological processes or that localize to the same functional
modules are also reported to be subject to a similar regulatory
process and generally covary (Foster et al., 2006). To validate
and identify which of these 192 proteins vary synchronously,
we computed the robust Spearman correlation network for all
protein pairs using the full SRM data set (Figure 1D). The result-
ing network contained 82 correlated nodes (proteins) with 211
edges in 3 main enrichment clusters. As expected, proteins
within ontologies are highly correlated such as for mitochondria
(Figure 1Da) and lipidmetabolism (Figure 1Db).Within Figure 1Da
are five of the six measured proteins involved in mitochondrial
unfolded protein response (UPRmt) (HSPD1, HSPE1, HSPA9,
CLPP, and LONP1, indicated in red), along with three of the
four measured NADH dehydrogenase genes (NDUFA1, NDUFB3
and NDUFS6, in blue) and four of the eight measured mitochon-
drial-encoded proteins (MT-CYB, MT-CO2, MT-CO3, and MT-
ND3, in black). Meanwhile, proteins involved in carbohydrate
metabolism are enriched in the same cluster (Figure 1Dc). These
results show that functionally related proteins tend to be coordi-
nately regulated at a protein level and that coregulation of protein
abundance is strongly maintained for certain processes. To vali-
date the biological significance of these function-based covaria-
tion clusters, we further investigated one: the UPRmt network
(elaborated in Figure 6).
Protein and mRNA Gene Products Generally Do Not
Correlate
With the general protein measurements validated, we generated
a global overview of how genotype and diet influence differen-
tial transcript and protein expression (Figure 2A; numerical
values listed in Table S1 available online). At the genetic level,
transcripts and proteins map to an equivalent number of sig-
nificant QTLs: we detected 65 significant transcript QTLs
(eQTLs—blue lines at the center) and 57 significant protein
QTLs (pQTLs—red lines at the center). However, though the total
number of eQTLs and pQTLs are roughly equivalent, the pre-
dominant type of regulationwas very different: 74%of the eQTLs
are cis-mapping (ratio of solid to dashed blue lines), versus only
31%of pQTLs (ratio of solid to dashed red lines). This indicates a
closer connection between a transcript and its gene than a pro-
tein and its gene. In general, trans-mapping proteins and tran-
scripts mapped evenly across the genome, not yielding any clear
‘‘hot spots’’ for these metabolic genes (sample magnification of
QTLs mapping to chromosome 5 is shown in Figure 2B).
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Figure 1. SRM-Based Protein Quantification and Covariation Network
(A) SRM assay development for targeted proteomic measurements; 309 peptides corresponding to 192 genes were designed and synthesized via SPOT syn-
thesis. Fragment ion spectra were generated on a triple-quadrupole MS with the SRM-triggered MS2 mode, and then ions were selected based on their relative
intensities. Dot colors indicate different amino acids. The following abbreviation was used: m/z, mass-to-charge ratio. Mouse liver homogenate combined with
the heavy reference proteomewas analyzed with SRM on a triple-quadrupoleMS. Different dot colors represent different peptides (Quadrupole 1) or product ions
(Quadrupole 3).
(B) Biological replicates had near-perfect reproducibility (r2 ! 0.98), shown here for all three biological replicates of the BXD60 CD cohort.
(C) Two-way cluster analysis of protein (top) and transcript (bottom) abundances in all 77 cohorts (40 CD, 37 HFD). Columns are clustered based on samples, and
rows are clustered based on gene-product abundances. Protein and transcript abundances are colored in a red-blue scale. Red, high abundance; blue, low
abundance; white, missing data.
(D) Protein association network based on robust Spearman correlation measures for all protein pairs. Statistically significant and strong positive associations
(p < 0.01 and r > 0.6) are edges. The largest correlation clusters are labeled ‘‘a,’’ ‘‘b,’’ and ‘‘c.’’ Nodes are labeled with protein names and colored according to their
biological process, as reported by DAVID (Huang et al., 2009).
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Within each diet, we found proteins and transcripts to be
nominally correlated for !25% of genes (i.e., Spearman corre-
lation p value < 0.05; Figure 2C, diets considered separately),
similar to findings in other species and populations (Foss
et al., 2007; Ghazalpour et al., 2011; Schwanha¨usser et al.,
2011; Skelly et al., 2013). Of the correlated transcript-peptide
pairs (46 in CD, 55 in HFD), 31 correlate significantly in both
cohorts, whereas 70 pairs correlate in only one dietary cohort.
Correspondingly, while !50% of genes were affected by diet,
transcripts were more frequently influenced (84 of 189) than
proteins (37 of 192), with only 21 genes affected at both
the transcript and protein levels (Figure 2D). Genes that were
the most strongly affected by diet at the transcript level (Fig-
ure 2E) tend to be similarly affected at the protein level (Fig-
ure 2F)—e.g., Cyp3a11 is higher in CD—though exceptions
are frequent, e.g., Srebf1 mRNA is induced by HFD, but unaf-
fected at the protein level, while in another counterexample,
the HFD cohorts have more ETFDH protein, but less of the tran-
script. Thus, while transcripts and proteins are moderately co-
varying estimations of their gene’s activity and typically have
covarying responses to external factors (e.g., diet), these trends
are too weak to support the measurement of any one particular
transcript to serve as a proxy for the protein (or vice versa)
without prior knowledge.
Most Transcript and Protein QTLs Do Not Overlap
Of the 192 target genes, 79 map to a significant eQTL or pQTL in
at least one dietary condition. A strong majority of significantly
mapped QTLs, !80%, are unique to either the transcript level
or protein level (Figure 3A). At the transcript level, 28 genes
map to cis-eQTLs, 20 of which are in both diets, while 17 tran-
scripts map as trans-eQTLs, none of which are observed in
both diets. Together, we observed 65 significant eQTLs stem-
ming from 45 distinct genes (Figure 3B, left; the 20 distinct genes
that map cis in both diets contribute 40 significant eQTLs). The
range of transcript variance within a diet was a strong predictive
factor for observing an eQTL. Transcripts in the least variable
quartile (range < 1.5-fold from the lowest to the highest express-
ing BXD strain) contained only 10% of the significant QTLs. In
contrast, the second quartile (range 1.5- to 1.65-fold) contained
17%, the third quartile (range 1.65- to 2.0-fold) contained 29%,
and the top quartile (rangeR 2.0-fold) contained 41% of the sig-
nificant QTLs.
At the protein level, 57 significant pQTLs stem from 48 distinct
proteins (Figure 3B, right). In striking contrast to transcript regu-
lation, only 13 distinct proteins map to cis-pQTLs, five in both di-
ets, while 36 proteins map as trans-pQTLs. No trans-pQTLs are
consistent across diets, although three proteins significantly
map to separate trans-pQTLs in both diets (Cd44, Acss2, and
Ndufs6), and one (Hmgcs1) maps to both cis- and trans-pQTLs.
Together with transcript data, we could moderately predict
pQTLs: of the 28 genes with cis-eQTLs, 12 correlated well (r >
0.40) between the transcript and protein. Of these 12 genes,
five (Dhtkd1, Nnt, Tymp, Gclm, and Bckdhb) map significantly
as pQTLs and eQTLs in both diets (Figures 3C, 3D, S2A, and
S2B; Bckdhb in Figure 4B), and four (Acox1, Mfn1, Mri1, and
Pm20d1) map as pQTLs and eQTLs in at least one diet. Interest-
ingly, three proteins mapped as cis-pQTLs and correlated with
their transcript, but did not have associated eQTLs (Hmgcs1,
Car3, and Acsf2), suggesting the genetic variant driving these
changes manifests more prominently at the protein level than
at the transcript level (e.g., Figure 3E).
Diet also plays a clear role in the consistent identification of
cis-QTLs. For the 20 genes with cis-eQTLs identified in both
diets, HFD significantly affects the levels of only one (Pmpcb;
Figure 3F). Conversely, for the eight genes mapping to an
eQTL in only one diet, the levels of only three are affected
(Ndufs2, Acads, and Aldh4a1). Similar trends are observed at
the protein level: of the five cis-pQTLs found in both diets,
none are affected by diet, while for the eight genes with cis-
pQTLs in only one diet, only the levels of one (Hmgcs1) are
affected. This relationship is similar for trans-eQTLs: of the 17
genes with trans-eQTLs, only four are influenced by diet
(whereas!50% of total transcripts are influenced by diet). How-
ever, diet does not appear to strongly influence trans-pQTLs,
where 11 of the 39 are affected by diet, a similar proportion to
the overall effect, recalling that !20% of proteins have levels
influenced by diet (Figure 2D). Together this suggests diet can
change the genetic factors regulating these genes without
changing their overall levels.
While high expression variability is associated with stronger
QTLs, it is not a definitive predictor, e.g.,Mup3 is highly variable,
Figure 2. mRNA and Protein Overview
(A) Circos plot of mRNA and protein data for all 192 genes, labeled on outer edge. Genes are represented by two bars: light for CD and dark for HFD. Genes are
arranged by relative chromosome position; the chromosome length is according to number of genes measured. Blue bars indicate the transcript relative
expression CD versus HFD; orange bars indicate the protein relative expression CD versus HFD. Bars with more unequal heights indicate diet has a larger impact.
Green bars indicate the correlation between the transcript and protein for each gene within each diet. Fuchsia bars represent the strength of the peak eQTL.
Yellow bars represent the strength of the peak pQTL. The two bars are overlaid with transparency. The dashed green line represents the simplified significance
cutoff (LRS R 18). The inner ring indicates the chromosome location. The blue central lines represent significant eQTLs, and the red central lines represent
significant pQTLs. The central solid lines represent cis-QTLs, and the central dashed lines represent trans-QTLs. QTL lines stem from the LRS bar graph and
terminate on the inner side of the chromosome ring at the approximate QTL location.
(B) Magnified view of eQTLs and pQTLs mapping to chromosome 5.
(C) In CD !25% (left), and in HFD !30% (right), of transcripts correlate nominally significantly with their protein. The lower strip charts show correlation distri-
bution. Spearman correlation values corresponding to nominal significance (p < 0.05) and corrected significance (p < 0.0002) are displayed on the axis.
(D) Venn diagram of genes that are differentially regulated between CD and HFD as transcripts (blue), proteins (red), both (purple), or neither (gray).
(E) Volcano plot for mRNA showing the magnitude of dietary effect versus significance. !45% vary with nominal significance (p < 0.05) between the dietary
conditions. Approximately 19% vary with corrected significance (raw p < 0.0003). Some extreme genes are labeled.
(F) Plot of the effect of diet on transcripts versus the effect of diet on proteins. In general, transcripts and proteins are similarly affected by diet.
Related to Tables S1 and S2.
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Figure 3. QTL Overview
(A) Venn diagram separating all genes with distinct QTLs based on provenance.
(B) Venn diagrams separating eQTLs or pQTLs by dietary source and regulatory mechanism. Overlapping regions indicates genes giving an eQTL or pQTL in both
diets; white numbers are counted twice for QTL count, but once for distinct gene count (e.g., there are 48 significant cis-eQTLs, which stem from 28 distinct
genes).
(C) In both diets, DHTKD1 and Dhtkd1 share a common cis-QTL, are unaffected by diet, and strongly correlate.
(legend continued on next page)
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strongly affected by diet, and consistently expressed between
mRNA and protein, but does not map to a QTL in any measure-
ment (Figure 3G). Therefore, while the ability to predict peptide
levels based on transcript measurements on a systems scale
is quite powerful (the !25% to !37% of correlated transcript-
peptide pairs is much better than the!5% expected by chance),
the probability to fail of any one particular gene is quite high.
These chances can be adjusted somewhat—perturbations
dramatically affecting transcript levels aremore likely to manifest
at the protein level and vice versa—but even so, prior research
must be established before gene expression can be confidently
considered a proxy for protein levels in targeted genetic studies.
This also indicates that applying quantitative proteomic data to
pathways established at the transcript level can indicate new
links that were previously obscured.
Functional Relationships of pQTLs to Phenotypes
To characterize the cellular function and potential physiological
relevance of the pQTLs, we first collated all Entrez (Maglott
et al., 2005) and UniProt (Magrane and Consortium, 2011) entries
for genes with the most significant pQTLs (LRSR 20) (Table 1).
As the BXDs have extensive historical phenotype andmetabolite
data available on GeneNetwork (Wang et al., 2003), we per-
formed a phenome-wide association study to determine if any
collected phenotype data mapped at least suggestively (likeli-
hood ratio statistic [LRS] R 12) as clinical QTLs (cQTL) to the
same loci. A handful of phenotypic connections in the BXDs
were supported by literature, including a link between Nnt and
insulin (Wong et al., 2013) and between Car3 and subcutaneous
adiposemass (Mitterberger et al., 2012). However, for themajor-
ity of pQTLs, no established cQTLs mapped to the same loci.
We thus selected the two genes with the most significant and
novel pQTLs in both diets for follow-up analysis and valida-
tion—Bckdhb and Dhtkd1.
Bckdhb is a subunit of the branched chain amino a-keto acid
dehydrogenase (BCKD, EC 2.7.11.4) complex (Figure 4A) and
maps to two of the most significant eQTLs and among the
most significant consistent pQTLs (Figure 4B; Tables 1 and
S1). Bckdhb transcript and protein levels are highly variable
across strains and are unaffected by diet (Figure 4B), but no
cQTL mapped to this locus. In humans, variant alleles of
BCKDHB are known to cause Type IB maple syrup urinary dis-
ease (MSUD), an inborn error of metabolism characterized by a
buildup of branched chain amino acids (BCAAs) and branched
chain a-keto acids (BCKAs). MSUD manifests in newborns and
is associated with neurological problems and delayed develop-
ment, and if untreated it can be fatal (Chuang and Shih, 2001).
This pathway is a multi-tissue system driven particularly by the
muscle and liver, and consequently it is diagnosed by significant
increases of BCAAs and BCKAs in both the serum and urine, a
decrease in alanine, and/or by detection of L-alloisoleucine
(Chuang and Shih, 2001; Haymond et al., 1978). Genetically en-
gineered mouse models of MSUD have similar phenotypic pro-
gression as humans, including the same metabolite buildups
and related phenotypes such as movement difficulties and
reduced body growth (Koepp et al., 1974; Wu et al., 2004). We
thus examined the BXDs with respect to these traits. While L-al-
loisoleucine was not detected, strains with the less functional B6
allele ofBckdhb had amarked increase in the BCAA/alanine ratio
in the serum and liver (Figure 4C, left and right, respectively).
However, no association with movement, growth or body weight
was present in the BXDs (data not shown), suggesting that this
Bckdhb variant carries only the subclinical metabolic effects of
MSUD. This observation is also in line with the human disease,
where MSUD symptoms are only apparent when BCKD activity
is < !30% of normal (Skvorak, 2009). In contrast, strains with
the B6 allele of Bckdhb have !50% the enzymatic activity
compared to those with the D2 allele. However, this raises the
possibility that a sustained BCAA loading test in the BXDs may
lead to clinical manifestation of the intermittent form of MSUD.
To continue scanning for physiological links with the proteins
examined, we also investigated the strongest pQTL in both diets.
This gene,Dhtkd1, encodes amitochondrial protein operating as
the E1 subunit of a dehydrogenase complex involved in lysine
metabolism (EC 1.2.4.2; Figure 4D). In humans, variants in
DHTKD1 have been linked to urinary buildup of 2-aminoadipate
(2-AA) and 2-oxoadipate, yet the few studies on the physiological
consequences of these variants are conflicted (Danhauser et al.,
2012; Houten et al., 2013; Xu et al., 2012). After measuring the
metabolites involved in this pathway in the BXD liver and serum,
we observed a striking correlation between DHTKD1 levels
and 2-AA (Figure 4E, left) as well as between metabolites in
the pathway itself (Figure 4E, right and Figure S2A). Moreover,
2-AA mapped significantly in both diets as an mQTL to the locus
of Dhtkd1 itself, indicating the BXDs share an inborn error of
metabolism similar to humans (Figure 4F). Due to the strength
and consistency of this correlation across diets, we hypothe-
sized this variant may lead to phenotypic consequences and
inform for human validation.
DHTKD1: A Regulator of Glucose Homeostasis
Inhibition of DHTKD1 in human liver cells is known to diminish
mitochondrial activity (Xu et al., 2013), and external administra-
tion of 2-AA improves insulin secretion in mice (Wang et al.,
2013). We thus examined whether the natural genetic variants
in Dhtkd1 may also influence glucose homeostasis in the
BXDs. The BXDs have varying responses to HFD-induced diabe-
sity and include some resistant strains, but most strains are
affected, leading to general increases in liver weight, serum
cholesterol, glucose, and overall body weight (Figures 5A and
S2B). Strikingly, 2-AA is negatively associated with liver mass
and fasted glucose levels in both diets, and with serum choles-
terol and insulin in CD (Figure 5B). Other metabolites in this
pathway were also connected to the same phenotypes and
(D) NNT and Nnt display a similar pattern.
(E) Car3 has only one significant pQTL despite an absence of dietary effect and a strong transcript-protein correlation.
(F) PMPCB does not map to a significant pQTL; however, Pmpcb maps to a significant cis-eQTL in both diets, despite a strong transcriptional upregulation by
HFD. The transcript and protein levels do not correlate.
(G) Mup3 and MUP3 do not map to significant QTLs, despite having high levels of variation and a strong transcript-protein correlation.
Related to Figure S1.
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Figure 4. Metabolic Consequences of BCKDHB and DHTKD1
(A) BCKDHB is the E1b subunit of the BCKD complex, which irreversibly converts several BCKAs.
(B) Bckdhb mRNA has the strongest eQTLs of the 192 target genes examined in the liver and has among the strongest pQTLs. Neither transcript nor protein is
affected by diet.
(C) The BCAA/alanine ratio is significantly increased in animals with the dysfunctional C57BL/6 allele in CD serum and liver measurements and HFD liver
measurements, in line with it acting as a risk for MSUD. Red line represents median of strains with the C57BL/6 allele, and purple lines represent the median of
strains with the DBA/2 allele.
(D) DHTKD1 is the E1 subunit of the dehydrogenase complex that catalyzes the irreversible conversion of 2-oxoadipate to glutaryl-CoA.
(E) Left: serum 2-AA levels are strongly related to DHTKD1, as are liver levels (not shown). Right: other upstream metabolites in the DHTKD1 pathway correlate
strongly with one another, e.g., 2-AA and 2-AA semialdehyde, shown here in liver.
(F) Serum 2-AA maps as an mQTL in both diets to proximal chromosome 2, the location of DHTKD1.
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with negative correlation [e.g., saccharopine (Figure 5C) and
a-ketoglutarate (Figure S2C)]. Interestingly, 2-AA levels are
significantly decreased in the HFD cohorts (Figure 5D), despite
the genetic regulation of 2-AA by Dhtkd1 being equivalent be-
tween CD and HFD cohorts (Figures 4E and 4F). However, this
decrease is not directly linked to diet, but instead with the
animals’ progression toward diabetes. Based on HOMA insulin
resistance indices (Lee et al., 2008), most HFD-fed BXD animals
(108 of 180) became glucose intolerant and insulin resistant over
the six-month period of the dietary challenge (Figure S2D).
Conversely, only 18%of CD animals (29 of 165) have poor insulin
sensitivity. Strikingly, the changes in 2-AA levels go in tandem
with the HOMA index: animals with worse insulin sensitivity
have lower 2-AA, and animals with good insulin sensitivity have
Table 1. pQTLs Link to Phenotypes
Protein Diet LRS QTL Area [Mb] Gene Function Phenotype
DHTKD1 CD 43 Chr2: 3–8 cis lysine catabolism Reye syndrome, glucose regulation
DHTKD1 HFD 41 Chr2: 3–8 cis lysine catabolism Reye syndrome, glucose regulation
NNT CD 37 Chr13: 119–120 cis NADPH regeneration insulin secretion
GCLM HFD 34 Chr3:118–124 cis glutathione synthesis detoxification, ischemia, anemia
NNT HFD 31 Chr13: 119–120 cis NADPH regeneration insulin secretion
PRPS1 CD 31 Chr6: 61–66 73 nucleotide synthesis arts syndrome
GPX1 CD 30 Chr11: 119–122 70 glutathione peroxidase detoxification, cardiomyopathy
PM20D1 HFD 29 Chr1: 134–137 cis zinc binding (putative) tuberculosis sensitivity
MT-ND3 CD 28 Chr3: 11–18 21 complex I subunit Leigh syndrome
CMAS CD 28 Chr7: 95–105 70 sialic acid adhesion fibrosarcoma, dermatomyositis
MRI1 CD 28 Chr8: 88–90 cis tyrosine phosphorylation cell invasion regulation
NDUFS6 CD 27 Chr3: 11–18 21 complex I subunit lactic acidosis
PUM2 HFD 27 Chr10: 106–109 7 RNA binding development, cell differentiation
BCKDHB CD 26 Chr9: 83–85 cis BCAA degradation maple syrup urinary disease
BCKDHB HFD 24 Chr9: 83–83 cis BCAA degradation maple syrup urinary disease
TYMP CD 24 Chr15: 89–90 cis thymidine phosphorylation angiogenesis, mtDNA regulation
RPL18A CD 24 Chr3: 25–31 33 ribosome 60S subunit hepatitis susceptibility
CAR3 CD 24 Chr3: 14–21 cis carbon dioxide hydration laryngeal disease, adipogenesis
DAK HFD 24 Chr4: 128–130 34 dihydroxyacetone kinase, FMN glycerolipid metabolism
NDUFA4 HFD 24 Chr11: 33–40 5 complex I subunit glucose regulation
ACADS CD 23 Chr5: 67–76 42 beta oxidation, short chain SCAD deficiency
HMGCS1 HFD 23 Chr4: 80–84 10 cholesterol synthesis cholesterolemia
FASN CD 23 Chr5: 137–139 38 fatty acid synthesis obesity
GCLM CD 23 Chr3: 118–124 cis glutathione synthesis ischemia, anemia
ABCE1 CD 23 Chr13: 114–121 28 ribonuclease L inhibitor viral load, RNA stability
ABCB8 CD 23 Chr5: 23–25 cis mito membrane transporter iron homeostasis
ARG1 HFD 22 Chr11: 64–66 13 urea cycle argininemia, hyperammonemia
DCN HFD 22 Chr11: 51–52 11 collagen assembly cell growth and proliferation
AKR7A2 HFD 22 Chr1: 23–24 cis succinic semialdehyde redox detox of aldehydes and ketones
AFP HFD 21 Chr6: 86–88 29 fetal serum albumin (putative) copper, fatty acid, bilirubin binding
COPB1 CD 21 Chr16: 8–15 56 Golgi complex transporter lipid storage, LDL levels
ACSS2 HFD 21 Chr11: 115–121 101 acetate activation lipid synthesis, energy generation
TYMP HFD 21 Chr15: 89–90 cis thymidine phosphorylation angiogenesis, mtDNA regulation
COX6C CD 20 Chr7: 141–144 14 cytochrome C electron transfer energy generation
MYBBP1A HFD 20 Chr14: 112–116 1 regulation of ribosomal DNA nucleolar stress response
GSTK1 HFD 20 Chr4: 67–70 3 glutathione regulation cellular detoxification
EPAS1 HFD 20 Chr10: 106–109 7 O2-responsive transcription factor erythryocytosis, hypoxia response
ACSF2 CD 20 Chr11: 116–118 cis fatty acid metabolism tuberculosis sensitivity
SRSF7 HFD 20 Chr15: 40–48 11 spliceosome, mRNA export immune response
A list of all genes with highly significant (LRSR 20) pQTLs. For each gene, the significant peak QTL width considers a 5 LRS drop-off on either side of
the peak. A count of all genes under the wide peak is displayed, unless it is a cis-pQTL as the candidate gene can be easily identified (itself). The cellular
function and overt physiological effect described by literature for each gene is given.
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Figure 5. Physiological Consequences of DHTKD1 Variants
(A) Liver size, serum cholesterol, and fasted glucose levels increase after HFD across the BXDs. Error bars represent mean + SEM.
(B) In CD livers, 2-AA is associated negatively with liver mass, serum cholesterol, insulin, and glucose. In HFD livers, 2-AA is associated negatively with liver mass
and fasting glucose.
(C) Liver levels of saccharopine, a metabolite upstream of 2-AA, are also associated negatively with the same phenotypes, although only in CD.
(D) 2-AA levels in the liver are significantly decreased in HFD-fed BXD cohorts.
(E) However, when correcting for diabetes status (HOMA-IR > 10 as diabetic, or HOMA-IR < 5 as healthy), there was no difference between CD andHFD—instead,
only between diabetic and nondiabetic cohorts.
(legend continued on next page)
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equivalent levels of 2-AA, with no effects linked directly to diet
(Figure 5E). With this in mind, we further examined 2-AA in two
independent population studies. In the Hybrid Mouse Diversity
Panel, a recent profile of liver metabolomes in 96 cohorts in the
fasted state contained 2-AA measurements (Ghazalpour et al.,
2014). In this diverse population, which includes!30BXD strains
(with only one strain overlapping with those in our study), 2-AA is
diminished in cohorts with higher fasted glucose (Figure 5F), and
the two are again negatively correlated (Figure S2E). Likewise,
we observed the same trend in a human population study (Co-
horte Lausannoise [CoLaus] study [Firmann et al., 2008]), in
which we recently analyzed the spot urine samples of 835 mid-
dle-aged or elderly individuals (Rueedi et al., 2014). In this
cohort, diabetic patients (Figure S2E) also displayed a marked
decrease in 2-AA levels (Figure 5F). Together, these findings
indicate that Dhtkd1 plays a major role in the regulation of
2-AA in both mice and humans and that the modulation of this
pathway may influence the development of diabetes.
The Mitochondrial Unfolded Protein Response
The UPRmt is a mitochondrial stress response pathway that is
activated by proteostatic stress, such as by accumulation of un-
assembled or unfolded proteins in the mitochondria (Zhao et al.,
2002), by the presence of an imbalance between mitochondrial
and nuclear encoded proteins (Houtkooper et al., 2013), or by
electron transport chain defects (Durieux et al., 2011; Runkel
et al., 2013). The activation of UPRmt in turn leads to the tran-
scription and translation of nuclear-encoded protective genes
such as mitochondrial chaperones and proteases to reestablish
mitochondrial proteostasis (reviewed in Haynes et al., 2013; Jo-
vaisaite et al., 2014; Wolff et al., 2014). The bulk of research on
UPRmt has taken place using C. elegans and mammalian cell
lines, thus little is known about when or howUPRmt occurs in vivo
inmammals. Furthermore, as the UPRmt is a stress response tied
to maintaining mitochondrial protein balance, we hypothesized
that its protein correlation networks may be different than those
generally examined at the transcriptional level.
In the worm, two ‘‘classical’’ approaches have been typically
used to induce UPRmt: the loss of function of cco-1, a nuclear en-
coded component of the electron transport chain (Durieux et al.,
2011), or the loss of function of spg-7, a mitochondrial protein
quality-control protease (Yoneda et al., 2004). We confirmed
that the knockdown of either gene by RNAi triggers the UPRmt
response in C. elegans, by strong induction of the mitochondrial
chaperone hsp-6 and of the proteases lonp-1 and clpp-1 (Fig-
ure 6A). Moreover, we linked this UPRmt activation to specific
phenotypes—a major reduction in size and mobility, as well as
a decrease in oxygen consumption—which are consequences
ofmitochondrial stress (Figure 6B). However, it has not been pre-
viously shown whether this coordinated regulation of UPRmt
genes is conserved in mammals in vivo.
In the BXDs, we investigated the expression of six members of
the UPRmt pathway, which are well conserved from C. elegans:
mitochondrial chaperones (Hspd1, Hspe1, Hspa9), proteases
(Clpp, Lonp1), and a transcriptional regulator involved in UPRmt
(Ubl5). These UPRmt genes are also coordinately regulated at
both mRNA and protein level in the BXDs, but with much stron-
ger connections among proteins (Figure 6C). Moreover, the
UPRmt network correlates negatively with Cox5b and Spg7
(mouse orthologs of worm cco-1 and spg-7, respectively), indi-
cating that low abundance of these genes amplifies UPRmt in
mammals as in C. elegans (Figure 6D). The network is also influ-
enced in part by diet. While Cox5b expression patterns are
similar between CD and HFD, Spg7 covariation is disjointed be-
tween the dietary cohorts (Figure 6E). This may explain why,
despite a similar overall UPRmt response in both diets (Figures
6D and 6F), Spg7 trends positively in HFD cohorts, while
Cox5b remains consistent (Figure 6G). Using four large tran-
scriptional studies of human tissue biopsies, we observe similar
transcriptional links, particularly including a strong network be-
tween all the UPRmt genes (Figure 6H). In humans, SPG7 is a
consistent negative correlate of this network, in contrast to
COX5B, which generally has positive covariation with the UPRmt
response (Figure 6I). Thus, while many of the overall regulators of
UPRmt remain coregulated across species—worm, mouse, and
human—particular nuances of its activation pathways appear
to be variable dependent on species, environment, tissue, and
likely other factors.
DISCUSSION
Due to major differences in transcript and protein regulation, it
has become increasingly clear that systems proteomics is
essential for the analysis of complex systems such as meta-
bolism (Khan et al., 2013; Skelly et al., 2013). Traditionally this
was attempted by semiquantitative immunoassays such as
ELISA or western blotting, yet these techniques allow only a
handful of proteins to be measured in parallel and are moreover
limited by the scarcity of quantitative immunoassays and the
dubious quality of many antibodies (Marx, 2013). Recent
shotgun proteomics experiments on diverse populations have
provided fundamental data on protein variance in populations
of yeast (Albert et al., 2014; Skelly et al., 2013), mammals (Gha-
zalpour et al., 2011), and humans (Hwang et al., 2010). However,
the inability to measure target proteins has limited the applica-
tion of this approach in the study of disease pathways. New
developments inmass spectrometry have led to SRM, a targeted
quantitative systems proteomics technique in which choice
proteins can be quantified based on a priori information. This
technique has been recently applied in a moderate-sized yeast
population study (Picotti et al., 2010), but until now it has not
been applied to study genetic regulation in multicellular species
or for a choice pathway.
In this study, we quantified 192 metabolism genes at the tran-
script and protein levels in livers from 77 cohorts of the BXDGRP
under two different dietary conditions. Along with sequence
(F) Using publicly available data from a recent metabolomic profiling of livers from the HMDP (Ghazalpour et al., 2014), we can observe that the inverse
relationship between 2-AA and fasted glucose is highly consistent in mouse populations. p = 0.01 if the four high nonoutliers in the low group are suppressed.
(G) Also in a human population study with urine metabolomics, diabetic patients had markedly lower levels of 2-AA.
Related to Figure S2.
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Figure 6. The Mitochondrial Unfolded Protein Response
(A) UPRmt induction in C. elegans triggered by interference with ETC (RNAi of cco-1) or mitochondrial proteostasis (RNAi for spg-7). These triggers result in
upregulation of UPRmt effectors hsp-6, clpp-1, and lonp-1 and a reduction in ubl-5. The orthologous mouse genes are indicated below the respective C. elegans
gene symbol. Error bars represent mean + SEM.
(B) UPRmt induction in C. elegans decreases movement, size, and oxygen consumption.
(C) UPRmt genes and proteins form a network of coordinately expressed mRNAs and proteins in vivo in mice, which is stronger at the protein than at the mRNA
level.
(D)Cox5b and Spg7 (orthologs of C. elegans cco-1 and spg-7) are generally negatively associated with the levels of all UPRmt genes in CD cohorts, particularly at
the protein level, in line with observations in the worm.
(E) While the levels of Cox5b and Spg7 are not affected by diet, expression is consistent by strain across the two diets only for Cox5b.
(F) The UPRmt network in HFD livers is similar to that observed in CD, but somewhat weaker. Ubl5 remains a striking negative correlate at the mRNA level.
(G) In HFD, Cox5b remains a negative correlate of UPRmt transcripts and proteins, while Spg7 does not.
(H) The features of the UPRmt network are also conserved in 427 human liver biopsies (Schadt et al., 2008), 405 lung biopsies (Ding et al., 2004), 180 lymphoblast
lines (Monks et al., 2004), and 43 hippocampi (Berchtold et al., 2008).
(I) In humans, SPG7 is a consistent negative correlate of the UPRmt transcripts.
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variants, basic metabolomics, and phenotype data, this com-
bined multilayered population data set enabled us to accurately
estimate abundance changes in gene products due to genotype,
diet, and gene-by-environment interactions (GXE). By comple-
menting these layers, we were able to tentatively link dozens of
pQTLs with phenotypes. Of the !50 of significant pQTLs identi-
fied, we established links between four genes leading to pheno-
typic consequence: two novel and two confirmatory. For these
genes, Nnt, Car3, Dhtkd1, and Bckdhb, coding differences be-
tween B6 and D2 alleles were linked to robust differences at
both the transcript level and protein level, leading to shared
cis-regulatory eQTLs and pQTLs and then to phenotypic conse-
quences. While Nnt has been previously attributed as causal to
differences in insulin secretion in the BXDs (Wong et al., 2013),
the other pQTLs are novel, including Car3, which was previously
linked to adiposity only in knockout mice (Mitterberger et al.,
2012). For Bckdhb, strains carrying the B6 allele have a !50%
reduction in enzyme levels, which leads to a buildup of BCAA
levels and a decrease in alanine levels, as in the intermittent
form of MSUD. In humans, MSUD is a rare inborn error of meta-
bolism, and while BXDs do not suffer any overt physiological
consequences of BCKDHB deficiency in the basal state, certain
dietary stresses may magnify the symptoms and make the BXDs
appropriate to model MSUD.
For Dhtkd1, the BXD strains map to highly significant and
overlapping eQTLs and pQTLs with an approximately bimodal
distribution with 2-fold variance between strains with the B6
(low) or the D2 allele (high) of the gene and with no effect from
diet. Furthermore, the metabolite 2-AA maps as a significant
mQTL to the Dhtkd1 locus in both diets, despite a marked
decrease of 2-AA levels in HFD cohorts. Interestingly the
decrease in 2-AA is not directly due to the HFD, but rather it is
due to the increased penetrance of insulin resistance after
HFD. Moreover, prior works show that external administration
of 2-AA can improve insulin sensitivity and glucose response
in mice (Wang et al., 2013), indicating that variants in Dhtkd1
and 2-AA levels may be driving the pathogenesis of diabetes,
rather than being mere passive biomarkers of the disease. Strik-
ingly, we replicated this association between 2-AA and high
glucose levels in a recent and completely independent metabo-
lomic data set collected in the Hybrid Mouse Diversity Panel
(Ghazalpour et al., 2014). Furthermore, and clinically relevant,
we demonstrated in a human population-based sample, Co-
Laus, that diabetic patients likewise have lower urinary levels
of 2-AA (Rueedi et al., 2014). Thus, 2-AA levels are consistently
linked to the diabetes status in bothmice and humans, and in the
BXDs we can unequivocally attribute a causal part of this vari-
ance to variants in Dhtkd1. The BXD strains were necessary to
bring the hypothesis to power a human study and also confirm
that the mouse link has relevance for human disease. Together,
these findings further validate the BXD mouse population as a
model for human metabolic diseases (Andreux et al., 2012),
and they indicate a critical need for multilayered measurements
to effectively analyze complex systems, particularly within the
context of the study of GXE.
It is worth stressing that novel regulatory mechanisms can be
found either through QTL analysis and their equivalent from
GWAS, SNP analysis, or through network analyses, which are
a complementary and powerful approach to dissect complex
traits. The network approach is particularly viable when backed
by high-depth multilayered data sets such as illustrated by our
example of UPRmt. UPRmt is a reparative pathway activated by
mitochondrial proteotoxic stress that has been primarily studied
in the C. elegans and in cultured cells, but little is known about
whether it occurs in vivo in mammals. We examined six genes
that are known to be major regulators of C. elegans UPRmt and
that are conserved in mammals. These six genes form a robust
coexpression network in both diets at the transcriptional and
proteomic levels, with the proteomic connections being stron-
ger, befitting the role of UPRmt as a sensor and regulator of pro-
tein stress. One observation that stood out in the analysis of the
UPRmt was the striking ‘‘contradiction’’ between the Ubl5 tran-
script and UBL5 protein correlations to the UPRmt network.
Ubl5 is a transcriptional regulator known to induce UPRmt; yet,
in both worms and mice, its transcript levels decrease when
UPRmt is activated. Conversely, the UBL5 protein is increased
with UPRmt activation in the BXDs, an observation also previ-
ously reported in C. elegans (Benedetti et al., 2006). This discor-
dance in protein and transcript regulation suggests the existence
of posttranscriptional mechanisms or a negative feedback loop,
which could not be detected at the transcript or protein level
alone. While there remains a great deal of this pathway left to
be explored, it is clear that accurate, systems-scale proteinmea-
surements are essential to effectively model complex protein
response networks like UPRmt.
Today, there is an unprecedented capacity for accurate mea-
surement quantification of nearly all aspects of biology. Surpris-
ingly, perhaps, proteins remain one of the most difficult aspects
of biology to precisely measure on a systems scale, though it has
been long clear that transcripts only serve as a weak proxy for
protein levels (Gygi et al., 1999). Our data show that the integra-
tion of systems proteomics data sets with different layered sys-
tems measurements provides unprecedented insights into the
mechanistic regulation of complex systems, such as exemplified
by metabolism, which can eventually lead to the improved diag-
nosis and treatment of metabolic disease.
EXPERIMENTAL PROCEDURES
Animals
Forty strains of the BXD population—40 on CD, 37 on HFD—with !10 male
animals from each strain were separated into 2 cohorts of 5 for each diet.
Food access was ad libitum for CD—Harlan 2018 (6% kCal/fat, 74% carbo-
hydrate, 20% protein)—and for HFD (Harlan 06414 [60% kCal/fat, 20% car-
bohydrate, 20% protein]). HFD cohorts received the diet from week 8 until
sacrifice. Each cohort was communally housed until week 23, after which an-
imals were single caged until tissues collection at 29 weeks after an over-
night fast. Tissues were collected from 183 CD and 168 HFD animals, with
at least 3 biological replicates for all cohorts. All research was approved
by the Swiss cantonal veterinary authorities of Vaud under licenses 2257.0
and 2257.1.
Sample Preparation and Analysis
For liver analyses, three !100 mg pieces were taken from cold storage for
each individual and then weighed and sorted for mRNA, protein, and metabo-
lite measurements. For microarray, mRNA from three to five individuals per
cohort were prepared separately and then pooled equally after nanodrop
quantification and run on the Affymetrix Mouse Gene 1.0 ST array platform.
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For proteomics, protein was prepared from one to three biological replicates
per cohort. For metabolite measurements, all individuals in all cohorts were
measured individually after polar extraction of samples.
SRM Assay Development and Protein Quantification
Generation of peptide library and development of SRMassayswere performed
as described (Picotti et al., 2010). Identical SRM assays for all 192 target
proteins were run on all 77 cohorts. SRM traces were manually checked ac-
cording to established criteria (Lange et al., 2008a). For relative quantification
of each protein across the set of different cohorts, the raw intensity of transi-
tions of the native and (13C6,
15N4)-Arginine, (
13C6,
15N2)-Lysine peptides
were considered. The technical reproducibility of SRM-based quantification
was validated by measuring the individual samples with three independent
mass spectrometry injections.
General Informatic Analyses
Outliers were Windsorized prior to all analyses. SNP analysis was also per-
formed using GeneNetwork, which contains the full sequence data of
C57BL/6J and DBA/2J, as well as high density genotype information for all
the BXD lines. The correlations are Pearson’s r or Spearman’s rho, depending
on the absence or presence of outliers. Student’s t test was used for
comparing two groups in normalized data (all protein and mRNA are normal-
ized). Bonferroni’s correction for multiple testing was performed, and cutoffs
for both nominal significance (p < 0.05) and corrected significance (p < 0.05/
n tests) are displayed. Except for QTL plots, graphs and analyses were
performed in R.
Metabolite Measurements
Murine metabolite measurements for this study were performed on serum and
livers from the BXDs using ultra performance liquid chromatrography-mass
spectrometry and flow-injection time-of-flight mass spectrometry, respec-
tively. Human urinalysis was performed on 835Caucasian adults in theCoLaus
study, including 43 diabetics and 792 nondiabetics, males and females. The
CoLaus study was approved by the Institutional Ethics Committee of the Uni-
versity of Lausanne. All study participants gave written consent. Full details of
the human NMR metabolomics data are in a separate parallel publication
(Rueedi et al., 2014).
Data Repository
All BXD data can be found at http://www.GeneNetwork.org. To download the
clinical phenotype data, change the type to ‘‘Phenotypes’’ and enter ‘‘LISP2’’
to find all associated results. Select all and export to recover the data, or
analyze it online. Microarray data and protein measurements can be found
on the same resource; change the type to ‘‘Liver Proteome’’ or ‘‘Liver
mRNA’’ and navigate to the named EPFL data sets under CD or HFD (e.g.,
EPFL/LISP BXD CD Liver Affy Mouse Gene 1.0 ST [Apr13] RMA). To download
these data, please click the ‘‘INFO’’ button at the right-hand side of the search
page and download the raw data set in the upper right box of the screen.
Extended Experimental Procedures and Supplemental References are
available in the Supplemental Information.
ACCESSION NUMBERS
All array data can also be found on the Gene Expression Omnibus (GEO) under
the accession number GSE60149.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, two
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2014.07.039.
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